160 related articles for article (PubMed ID: 27013655)
41. Serum mass profile signature as a biomarker of early lung cancer.
Widlak P; Pietrowska M; Polanska J; Marczyk M; Ros-Mazurczyk M; Dziadziuszko R; Jassem J; Rzyman W
Lung Cancer; 2016 Sep; 99():46-52. PubMed ID: 27565913
[TBL] [Abstract][Full Text] [Related]
42. Identification of urine protein biomarkers with the potential for early detection of lung cancer.
Zhang H; Cao J; Li L; Liu Y; Zhao H; Li N; Li B; Zhang A; Huang H; Chen S; Dong M; Yu L; Zhang J; Chen L
Sci Rep; 2015 Jul; 5():11805. PubMed ID: 26133466
[TBL] [Abstract][Full Text] [Related]
43. Urine Proteome Profiling Predicts Lung Cancer from Control Cases and Other Tumors.
Zhang C; Leng W; Sun C; Lu T; Chen Z; Men X; Wang Y; Wang G; Zhen B; Qin J
EBioMedicine; 2018 Apr; 30():120-128. PubMed ID: 29576497
[TBL] [Abstract][Full Text] [Related]
44. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy.
Whitney DH; Elashoff MR; Porta-Smith K; Gower AC; Vachani A; Ferguson JS; Silvestri GA; Brody JS; Lenburg ME; Spira A
BMC Med Genomics; 2015 May; 8():18. PubMed ID: 25944280
[TBL] [Abstract][Full Text] [Related]
45. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
46. Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.
Pavel AB; Campbell JD; Liu G; Elashoff D; Dubinett S; Smith K; Whitney D; Lenburg ME; Spira A;
Cancer Prev Res (Phila); 2017 Nov; 10(11):651-659. PubMed ID: 28877936
[TBL] [Abstract][Full Text] [Related]
47. MDC and BLC are independently associated with the significant risk of early stage lung adenocarcinoma.
Zhang Y; Yu K; Hu S; Lou Y; Liu C; Xu J; Li R; Zhang X; Wang H; Han B
Oncotarget; 2016 Dec; 7(50):83051-83059. PubMed ID: 27811371
[TBL] [Abstract][Full Text] [Related]
48. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
[TBL] [Abstract][Full Text] [Related]
49. Multiplexed Serum Biomarkers for the Detection of Lung Cancer.
Ma S; Wang W; Xia B; Zhang S; Yuan H; Jiang H; Meng W; Zheng X; Wang X
EBioMedicine; 2016 Sep; 11():210-218. PubMed ID: 27575387
[TBL] [Abstract][Full Text] [Related]
50. Nut Consumption and Lung Cancer Risk: Results from Two Large Observational Studies.
Lee JT; Lai GY; Liao LM; Subar AF; Bertazzi PA; Pesatori AC; Freedman ND; Landi MT; Lam TK
Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):826-836. PubMed ID: 28077426
[No Abstract] [Full Text] [Related]
51. Urinary ADAM12 and MMP-9/NGAL complex detect the presence of gastric cancer.
Shimura T; Dagher A; Sachdev M; Ebi M; Yamada T; Yamada T; Joh T; Moses MA
Cancer Prev Res (Phila); 2015 Mar; 8(3):240-8. PubMed ID: 25591790
[TBL] [Abstract][Full Text] [Related]
52. Potential Impact of Including Time to First Cigarette in Risk Models for Selecting Ever-Smokers for Lung Cancer Screening.
Gu F; Cheung LC; Freedman ND; Katki HA; Caporaso NE
J Thorac Oncol; 2017 Nov; 12(11):1646-1653. PubMed ID: 28818607
[TBL] [Abstract][Full Text] [Related]
53. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
[TBL] [Abstract][Full Text] [Related]
54. The metabolomic detection of lung cancer biomarkers in sputum.
Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
[TBL] [Abstract][Full Text] [Related]
55. Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.
Ribal MJ; Mengual L; Lozano JJ; Ingelmo-Torres M; Palou J; RodrÃguez-Faba O; Witjes JA; Van der Heijden AG; Medina R; Conde JM; Marberger M; Schmidbauer J; Fernández PL; Alcaraz A
Eur J Cancer; 2016 Feb; 54():131-138. PubMed ID: 26761785
[TBL] [Abstract][Full Text] [Related]
56. Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
Jung YJ; Katilius E; Ostroff RM; Kim Y; Seok M; Lee S; Jang S; Kim WS; Choi CM
Clin Lung Cancer; 2017 Mar; 18(2):e99-e107. PubMed ID: 27836219
[TBL] [Abstract][Full Text] [Related]
57. The blood proteome of imminent lung cancer diagnosis.
Lung Cancer Cohort Consortium (LC3)
Nat Commun; 2023 Jun; 14(1):3042. PubMed ID: 37264016
[TBL] [Abstract][Full Text] [Related]
58. Creatine riboside is a cancer cell-derived metabolite associated with arginine auxotrophy.
Parker AL; Toulabi L; Oike T; Kanke Y; Patel D; Tada T; Taylor S; Beck JA; Bowman E; Reyzer ML; Butcher D; Kuhn S; Pauly GT; Krausz KW; Gonzalez FJ; Hussain SP; Ambs S; Ryan BM; Wang XW; Harris CC
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35838048
[TBL] [Abstract][Full Text] [Related]
59. Urinary Biomarkers for Early Diagnosis of Lung Cancer.
Gasparri R; Sedda G; Caminiti V; Maisonneuve P; Prisciandaro E; Spaggiari L
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33923502
[TBL] [Abstract][Full Text] [Related]
60. Pilot study of plasma creatine riboside as a potential biomarker for cervical cancer.
Oike T; Osu N; Yoshimoto Y; Obinata H; Yoshikawa K; Harris CC; Ohno T
Heliyon; 2023 Jun; 9(6):e16684. PubMed ID: 37292314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
